AU2018903530A0 - Treatment for Alzheimer's Disease - Google Patents

Treatment for Alzheimer's Disease

Info

Publication number
AU2018903530A0
AU2018903530A0 AU2018903530A AU2018903530A AU2018903530A0 AU 2018903530 A0 AU2018903530 A0 AU 2018903530A0 AU 2018903530 A AU2018903530 A AU 2018903530A AU 2018903530 A AU2018903530 A AU 2018903530A AU 2018903530 A0 AU2018903530 A0 AU 2018903530A0
Authority
AU
Australia
Prior art keywords
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018903530A
Inventor
Michael Lionel Selley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenexus Pharmaceuticals Pty Ltd
Original Assignee
Xenexus Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Xenexus Pharmaceuticals Pty Ltd filed Critical Xenexus Pharmaceuticals Pty Ltd
Publication of AU2018903530A0 publication Critical patent/AU2018903530A0/en
Abandoned legal-status Critical Current

Links

AU2018903530A 2018-09-20 Treatment for Alzheimer's Disease Abandoned AU2018903530A0 (en)

Publications (1)

Publication Number Publication Date
AU2018903530A0 true AU2018903530A0 (en) 2018-10-04

Family

ID=

Similar Documents

Publication Publication Date Title
EP3773552A4 (en) Compounds for treating huntington's disease
EP3634953A4 (en) Compounds for treating huntington's disease
EP3268086A4 (en) Lsd for the treatment of alzheimer's disease
EP3377118A4 (en) Methods for treating alzheimer's disease and related disorders
EP3698649A4 (en) Agent for preventing or ameliorating alzheimer's disease
EP3633372A4 (en) Biomarker for alzheimer's disease
IL263188B (en) Treatment for parkinson's disease
EP3600027A4 (en) Lymphocyte-based morphometric test for alzheimer's disease
IL278813A (en) Gene therapy for alzheimer's disease
ZA202205344B (en) Gene therapy for alzheimer's disease
IL280326A (en) Small rna predictors for alzheimer's disease
EP3746057A4 (en) Method for preventing or treating alzheimer's disease
EP3835424A4 (en) Diagnostic drug and diagnostic method for alzheimer's disease
EP3601601A4 (en) LYMPHOCYTE-BASED PKCepsilon TEST FOR ALZHEIMER'S DISEASE
EP3537155A4 (en) Method for determining alzheimer's disease risk
EP3861352A4 (en) Novel biomarker for alzheimer's disease in human
EP3538095A4 (en) Methods for treating parkinson's disease
IL288266A (en) Gene therapy for alzheimer's disease
GB201915753D0 (en) Alzheimer's disease
AU2018903530A0 (en) Treatment for Alzheimer's Disease
EP3628008A4 (en) Compositions and methods for treating alzheimer's disease
EP3759079A4 (en) Amyloid protein-selective bace inhibitors (asbis) for alzheimer's disease
EP3577224A4 (en) Novel treatment for neat1 associated disease
EP3804766A4 (en) Therapeutic agent for alzheimer's disease
ZA202006126B (en) Compounds for treating alzheimer's disease